Closed · RFA-AG-24-004 · CFDA 93.866 · Discretionary
Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial Not Allowed)
Federal grant opportunity posted by National Institutes of Health, cataloged on Grants.gov.
- up to $1M
- Award range
- Closed
- Status
- July 3, 2023
- Close date
- -
- Expected awards
The verdict
Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial Not Allowed) is a closed discretionary listing from National Institutes of Health that offered Up to $1,000,000. Future funding cycles may be published under the same CFDA number.
- up to $1M
- award range
- Closed
- application status
- 93.866
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Estimating the Monetary Costs of Dementia in the United States (U01 Clinical Trial Not Allowed) - is cataloged under number RFA-AG-24-004 and tied to CFDA assistance listing 93.866, posted by National Institutes of Health. Grants.gov currently shows the opportunity as closed, first posted on March 14, 2023. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is Up to $1,000,000. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on July 3, 2023. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
Up to $1,000,000
Close Date
July 3, 2023
Posted
March 14, 2023
Instrument
Cooperative Agreement
Description
This funding opportunity announcement (FOA) invites U01 applications to develop national cost of illness estimates for the monetary cost of Alzheimers Disease and Alzheimers disease-related dementias (AD/ADRD) in the United States using a societal perspective. The purpose of this FOA is to support development of a national estimate of the costs of AD/ADRD using population-representative and administrative data on older Americans through a comprehensive process that uses a family and People Living With Dementia engagement panel and a Technical Monitoring Committee. Applicants must describe administrative and convening activities - including a Family and People Living With Dementia engagement panel and a Technical Monitoring Committee - to guide cost estimate development and analyses. The awardee under this FOA must establish access to appropriate dataset(s) through NIAs data linkage support contract (MedRIC.info) and analyze the data to develop estimates of costs, including direct and indirect costs. Once data have been analyzed, the awardee will lead development of products to disseminate the methods and findings of the project, through the composition of manuscripts, data briefs, infographics, and presenting the findings of the project to the scientific community. The awardee will administer pilot projects to support cost simulations assessing treatment and policy changes that would alter the cost of disease. Analytic code and products of this work will be shared with the research community.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 25. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
NIH Grants Information grantsinfo@nih.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
More from National Institutes of Health
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Data Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative U24 Clinical Trial Required)
Development of Collaborative Research Facilities or Research-Resource Facilities (C06 Clinical Trial Not Allowed)
Research Grants in Clinical Informatics (R01 Clinical Trial Optional)
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |